People who bought listed generic prescription drugs in the United States between May 2009 and December 2019 may be able to share in a $400 million Sandoz settlement that a federal court preliminarily approved in October 2026. The state attorneys general direct consumers to file through their claims program by March 8, 2027.
What Happened?
The U.S. District Court for the District of Connecticut has preliminarily approved a $400 million settlement between a coalition of state attorneys general and the generic drug makers Sandoz Inc. and Fougera Pharmaceuticals Inc., according to an October 19, 2026 report by VitalLaw. The case is State of Connecticut v. Aurobindo Pharma USA, Inc., No. 3:20-cv-00802-MPS. Final approval will be decided at a fairness hearing.Connecticut Attorney General William Tong led 43 states and territories in asking the court to approve the deal on October 1–2, 2026. The states allege that Sandoz took part in a long-running conspiracy among generic drug makers to fix prices, rig bids and divide up customers. Sandoz has not been found liable, and the settlement resolves the allegations without a trial.
Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
Where the Money Goes
About 70% of the $400 million, roughly $280 million, is designated by the states as restitution, according to VitalLaw’s summary of the states’ approval motion. The remaining 30%, roughly $120 million, is held by the states to pay attorney fees and costs. The New York Attorney General says Sandoz will pay $320,560,180 with interest over seven years, bringing the total to $400 million. Counting earlier settlements Sandoz reached with individual states, it will pay about $469 million to state enforcers, the Connecticut Attorney General says.Sandoz also agreed not to engage in price-fixing, bid-rigging or market allocation involving generic drugs for ten years.
Who Can File and How
The attorneys general say people who bought listed generic prescription drugs in the United States between May 2009 and December 2019 may be eligible, and they direct consumers to the official program website, AGGenericDrugs.com, where the list of covered drugs and the claim form are posted. The New York Attorney General gives a claim deadline of March 8, 2027. That program already holds about $96.5 million from earlier settlements with Apotex, Heritage, Lannett, Bausch and Glenmark.The announcements do not say whether a claim already filed in the program will also count toward the Sandoz money or how the Sandoz share will be divided among consumers. No per-person amount has been published. OCA’s state attorneys general consumer settlement page covers eligibility, the covered-drug list and the claim process in detail.
Not the Same as the End-Payer Settlement
A separate $275 million Sandoz/Fougera settlement belongs to the private end-payer class action in Pennsylvania, which had its own claim form and a November 9, 2026 deadline that has passed. The $400 million settlement covered here is the states’ case and is claimed through the attorneys general program.What Happens Next?
The court will hold a fairness hearing before deciding whether to grant final approval; its date had not been published in the sources OCA reviewed. Claims in the attorneys general program stay open until March 8, 2027. The states’ case against other generic drug makers continues, with the first trial set for February 2027 in Hartford, according to the Connecticut Attorney General.Questions
Is the $400 million Sandoz settlement final?
No. The federal court in Connecticut granted preliminary approval in October 2026. Final approval will be decided after a fairness hearing.
How much of the $400 million goes to consumers?
About 70%, roughly $280 million, is designated by the states as restitution, according to a summary of the states’ approval motion. About 30%, roughly $120 million, is held by the states for attorney fees and costs. No per-person amount has been published.
Where do consumers file a claim?
The state attorneys general direct consumers to the official program website, AGGenericDrugs.com, which posts the covered-drug list and claim form. The New York Attorney General gives a March 8, 2027 deadline.
Is this the same as the $275 million Sandoz settlement?
No. The $275 million Sandoz/Fougera settlement is part of the private end-payer class action, whose claim deadline was November 9, 2026 and has passed. The $400 million settlement is the states’ case and is claimed through the attorneys general program.
Sources
- VitalLaw: States win preliminary approval of $400M Sandoz settlement (Oct. 19, 2026), citing State of Connecticut v. Aurobindo Pharma USA, Inc., No. 3:20-cv-00802-MPS (D. Conn.)
- Connecticut Attorney General: settlement with Sandoz
- New York Attorney General: $400 million Sandoz settlement (Oct. 1, 2026)
- Official state attorneys general claims program
